Alphatec Holdings, Inc. (ATEC)
10.46
-0.47
(-4.30%)
USD |
NASDAQ |
Oct 16, 16:00
10.45
-0.01
(-0.10%)
After-Hours: 20:00
Alphatec Holdings Research and Development Expense (Annual) : 76.27M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 76.27M |
| December 31, 2024 | 80.72M |
| December 31, 2023 | 70.12M |
| December 31, 2022 | 44.03M |
| December 31, 2021 | 32.02M |
| December 31, 2020 | 18.74M |
| December 31, 2019 | 13.85M |
| December 31, 2018 | 9.984M |
| December 31, 2017 | 4.92M |
| December 31, 2016 | 9.248M |
| December 31, 2015 | 17.62M |
| December 31, 2014 | 16.80M |
| Date | Value |
|---|---|
| December 31, 2013 | 14.19M |
| December 31, 2012 | 14.89M |
| December 31, 2011 | 16.89M |
| December 31, 2010 | 16.43M |
| December 31, 2009 | 13.49M |
| December 31, 2008 | 12.96M |
| December 31, 2007 | 6.36M |
| December 31, 2006 | 3.589M |
| December 31, 2005 | 0.9671M |
| December 31, 2004 | 1.177M |
| December 31, 2003 | 0.5205M |
| December 31, 2002 | 0.4157M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Artivion, Inc. | 30.99M |
| Glaukos Corp. | 150.61M |
| TransMedics Group, Inc. | 69.06M |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |